Introduction
============

Ketamine is a general anesthetic which has been reported to have a variety of cardiovascular effects: alteration of systemic arterial pressure with significant increases in heart rate, cardiac output, cardiac work and mediating myocardial oxygen requirements in normal humans with hypertensive properties. The mechanisms of these hypertensive actions are complex and thought to be via the central sympathetic nervous system \[[@B1]\]. Some studies also suggested that ketamine induces systemic hypotension and significantly alters distribution of blood flow to various organs \[[@B2],[@B3]\].

The mechanism of this cardiovascular effect is not clear, but it seems to be mediated by the changes in vascular tone through its direct action on vascular smooth muscle and/or endothelium \[[@B2]-[@B5]\]. It has been demonstrated that ketamine causes relaxation of vascular smooth muscle tone in a endothelium-dependent manner \[[@B4]\]. Therefore Lee and Hou \[[@B5]\] proposed that in endothelium-intact tissues, the direct action of ketamine on pulmonary arteries may not contribute to systemic hypotension during ketamine anesthesia. However in the absence of endothelium, contractile responses to norepinephrine and KCl were both inhibited during exposure to ketamine \[[@B4]\]. Thus, we speculated that in endothelium-denuded tissues, the direct inhibitory action of ketamine on mesenteric arterial smooth muscle cells may contribute to systemic hypotension during ketamine anesthesia \[[@B4]\]. The mechanism underlying the ketamine-induced vasorelaxation is supposed to be the increase in K^+^ conductance or the decrease in cytosolic Ca^2+^ levels (\[Ca^2+^\]~cyt~) \[[@B6],[@B7]\]. The contribution of K^+^ channels to ketamine-induced relaxation appears to be dependent on tissue sources, and species and agonist employed to induce vasorelaxation \[[@B6],[@B8]\]. The rise in \[Ca^2+^\]~cyt~ is an important determinant in contractions of vascular smooth muscle \[[@B9]\]. Previous studies on vascular smooth muscle have suggested that the direct inhibitory action of intravenous anesthetics is a result of both reduction of \[Ca^2+^\]~cyt~ and inhibition of the myofilament Ca^2+^ sensitivity \[[@B10],[@B11]\]. Furthermore, ketamine was reported to inhibit Ca^2+^ influx through L-type Ca^2+^ channels elicited by acetylcholine \[[@B7]\]. Therefore, it is possible that modulation of smooth muscle contraction by ketamine is due to the decrease in \[Ca^2+^\]~cyt~.

Based on previous studies, it is suggested that the effect and action mechanism of intravenous anesthetics may vary in potency or even in quality with different vascular tissues or even with different segments of the same artery. Considerable evidence also shows that propofol and ketamine induced hemodynamic changes but did not significantly affect renal blood flow \[[@B11]-[@B14]\]. Maintenance of renal blood flow may be important in clinical situations during intravenous anesthesia. Therefore it is necessary to know how ketamine affects responses of the renal artery to vasoconstrictors both in vivo and in vitro. However, less information is available regarding the effects of ketamine on renal smooth muscle. The aims of this study were designed to determine the effects of K^+^ channel blockers and Ca^2+^ store inhibitors on ketamine-induced relaxations in isolated rabbit renal arteries. We also test the hypothesis that the inhibitory effect of ketamine involved a decrease in influx of extracellular calcium.

Materials and Methods
=====================

Experimental preparations
-------------------------

All experimental procedures and protocols were approved by the Institutional Animal Care and Use Committee. Tension experiments were performed according to the method described. Fifty-five New Zealand white rabbits (2-3 kg) of either sex were killed by exsanguination after anesthesia with pentobarbital sodium (30 mg/kg, iv). The renal arteries were quickly excised and placed in a cold Krebs solution. The vessels were cut into 1 mm-wide ring segments and were placed in 3 ml tissue baths on 2 L-shaped hooks, one of which was attached to a force transducer for isometric measurement of tension. The vessel tension was recorded on a pen recorder. Before starting the experiments, the resting tension of 1 g was maintained throughout the experiments. Tissues were allowed to equilibrate for 90 min before each experiment.

The function of the endothelium was checked at the beginning of each experiment with acetylcholine (ACh). More than 50% of endothelium-intact, 1 µM norepinephrine-precontracted rings responding to ACh (1 µM) by relaxation were considered to have functionally intact endothelium and were accepted for further study. In some experiments, the endothelium was mechanically removed by gentle rubbing with moistened cotton, and its absence was confirmed by the lack of a relaxant response to ACh. Unless otherwise stated, L-N^G^-Nitroarginine Methyl Ester (L-NAME, 0.1 mM) was present in the physiological salt solution (PSS).

The contractile response induced by isotonic 50 mM KCl was measured for all renal arterial rings and used as a reference value (100%). After washing out the KCl from the organ bath and returning the isometric tension to the baseline resting tension, relaxations were studied in preparations contracted by either 50 mM KCl- or 10 µM histamine. When stable contractions were obtained, ketamine were added cumulatively to determine the concentration-response relationship. Each ring was used for only one ketamine concentration-response curve. The concentrations of ketamine used in these experiments were 0.1-100 µg/ml. The obtained IC~50~ values measured for ketamine following precontractions by 50 mM KCl and 10 µM histamine were 28.9 µg/ml and 26.7 µg/ml, respectively. Therefore we used 30 µg/ml ketamine (30 µg/ml) in the following experiments.

To investigate the effect of L-NAME (0.1 mM), K^+^ channel blockers and Ca^2+^ store inhibitors on ketamine-induced relaxations, renal arteries were precontracted with 10 µM histamine. Relaxation response to ketamine was calculated as percentage of the precontracted value; the stabilized tension after precontraction was determined as 100% and the baseline tension before precontraction as 0%. After washout with PSS, incubation with either L-NAME (0.1 mM), K^+^ channel blockers or Ca^2+^ store inhibitors was carried out for 30 min. The relaxing effect of ketamine was investigated in the absence and presence of either L-NAME (0.1 mM), K^+^ channel blockers or Ca^2+^ store inhibitors. In separate experiments with endothelium removed tissue, responses to histamine and ketamine were repeated again and then compared with endothelium-intact tissue.

To investigate the Ca^2+^ channel antagonistic effect of ketamine, concentration-response curves to CaCl~2~ (0.003-3 mM) were obtained in the absence and presence of ketamine (30 µg/ml). After renal artery rings were allowed to equilibrate for 30 min the rings were washed three times at 10-min intervals with Ca^2+^-free PSS which containing ethylene glycol bis (β-aminoethyl ether)-N,N,N\',N\',-tetraacetic acid (EGTA, 1 mM). The rings were then bathed with Ca^2+^-free, high K^+^ (50 mM) PSS with or without ketamine. After the rings were incubated with ketamine for 30 min, the concentration-response curves to CaCl~2~ were constructed. The concentration-response curves of CaCl~2~ were compared by repeated measures analysis to assess the effect of ketamine.

Solutions
---------

The composition of Krebs solution was as follows (in mM): NaCl 136.9, KCl 5.4, CaCl~2~ 1.5, MgCl~2~ 1.2, NaHCO~3~ 23.8, Ethylenediaminetetraacetic acid (EDTA) 0.01, glucose 5.5. EDTA was added to chelate the contaminated heavy metal ions. It was saturated with 95% O~2~ and 5% CO~2~ gas mixture at 37℃ to maintain pH at 7.4. The isotonic 50 mM KCl solution was prepared by replacing NaCl with an equimolar amount of KCl. In Ca^2+^-free solutions, CaCl~2~ was replaced with MgCl~2~.

Drugs
-----

Drugs used in this study were acetylcholine chloride, 4-aminopyridine (4-AP), EGTA, histamine dihydrochloride, iberiotoxin, ketamine hydrochloride, L,-NAME, norepinephrine hydrochloride, potassium chloride and tetraethylammonium (TEA) (Sigma, USA), ryanodine and thapsigargin (Calbiochem, USA), glibencamide (Tocris, UK).

Data analysis
-------------

Results were expressed as mean ± SEM. The number of preparations taken from separate animals was indicated by n. A one-way repeated-measurements of analysis of variance followed by Scheffe\'s F test for post hoc analysis, as well as paired t tests were used for the statistical analysis (Prism 5.0, GraphPad software, San Diego, CA, USA). P values of less than 5% (P \< 0.05) were considered statistically significant.

Results
=======

Effects of ketamine on KCl- and histamine-induced contractions
--------------------------------------------------------------

50 mM KCl and 10 µM histamine produced approximately the same amplitude of contraction, and we investigated the effects of ketamine on these similar contractions. In the endothelium-intact ring segments of rabbit renal arteries precontracted with either 50 mM KCl or 10 µM histamine, ketamine (0.1-100 µg/ml) induced a concentration-dependent relaxation (n = 8, [Fig. 1](#F1){ref-type="fig"}). The obtained IC~50~ values measured for 50 mM KCl- and 10 µM histamine were 28.9 µg/ml (105.5 µM) and 26.7 µg/ml (97.5 µM), respectively. In these experiments, treatment with 30 µg/ml ketamine significantly inhibited the histamine-induced contractions (54.3 ± 4.8, n = 8). Therefore we used 30 µg/ml ketamine (30 µg/ml) in the following experiments.

Effects of nitric oxide on ketamine-induced relaxation
------------------------------------------------------

Typical recordings of the response to ketamine in renal arterial rings with endothelium are shown in [Fig. 2A](#F2){ref-type="fig"}. The addition of 10 µM histamine induced a sustained increase in muscle tension. Ketamine (30 µg/ml), administered after histamine-evoked contraction reached a steady state, and elicited a sustained decrease in muscle tension. Ketamine-induced relaxation was not affected either by L-NAME (0.1 mM), nitric oxide (NO) synthase blocker, or by mechanical removal of the endothelium (n = 6), suggesting that ketamine-induced vasorelaxation was not mediated by NO (Control: 63.3 ± 6.5%, L-NAME: 59.3 ± 6.1%, and endothelium removal 67.4 ± 6.1%, n = 6) ([Fig. 2B](#F2){ref-type="fig"}).

Effects of K^+^ channels blockers on ketamine-induced relaxation
----------------------------------------------------------------

The contribution of K^+^ channels to ketamine-induced relaxation was assessed in the renal artery precontracted with 10 µM histamine. Ketamine-induced relaxation was significantly inhibited by either TEA (10 mM), non-specific K^+^ channel blocker, or by iberiotoxin (0.1 µM), an inhibitor of large conductance Ca^2+^-activated K^+^ channels (Control: 65.2 ± 5.8%, TEA: 47.8 ± 4.6%, and iberiotoxin 43.3 ± 4.5%, n = 6) ([Fig. 3](#F3){ref-type="fig"}). In contrast to the effects of large conductance Ca^2+^-activated K^+^ channels blockers, either glibenclamide (10 µM), the inhibitor of ATP-sensitive K^+^ channels or 4-AP (5 mM), a putative inhibitor of delayed rectifier K^+^ channel did not affect the relaxation to ketamine (Control, glibenclamide: 64.8 ± 6.1%, and 4-AP: 61.2 ± 5.9%, n = 6).

Effects of Ca^2+^ store inhibitors on ketamine-induced relaxation
-----------------------------------------------------------------

The possible involvement of Ca^2+^ store to ketamine-induced relaxations were assessed with thapsigargin or ryanodine in the rabbit renal artery precontracted with histamine (10 µM). Ketamine-induced relaxation was not inhibited following inhibition of Ca^2+^ release from sarcoplasmic reticulim with ryanodine (10 µM) or endoplasmic reticulum Ca^2+^-ATPase pathway with thapsigargin (10 µM) (Control: 66.8 ± 6.0%, thapsigargin: 59.7 ± 5.5%, and ryanodine: 57.3 ± 4.8%, n = 5) ([Fig. 4](#F4){ref-type="fig"}).

Effects of ketamine on Ca^2+^-induced contraction
-------------------------------------------------

In rings depolarized with 50 mM KCl solution in a Ca^2+^-free medium, the addition of cumulative addition of CaCl~2~ (0.003-3 mM) induced concentration-dependent contractions (n = 5, [Fig. 5A](#F5){ref-type="fig"}).

Pretreatment with 30 µg/ml ketamine slightly reduced basal tension and strongly inhibited CaCl~2~-induced contraction (n = 5, [Fig. 5B](#F5){ref-type="fig"}).

Discussion
==========

When a ketamine-involved anesthesia is performed, maintenance of renal blood flow is important in many clinical situations \[[@B15]\]. So, it is necessary to know how ketamine affects responses of the renal artery to vasoconstrictors like histamine and KCl. If the histamine- or KCl-evoked contraction of the renal artery takes place, it is important that ketamine-induced relaxation of the renal artery may affect or not affect renal blood flow and urine output.

Our finding clearly indicate that endothelium-independent relaxation induced by ketamine in rabbit renal arteries involves both activation of large conductance Ca^2+^-activated of K^+^ channels (BK~Ca~ channels) and inhibition of Ca^2+^ influx. Ketamine induced a concentration-dependent relaxation, which was not affected either by removal of endothelium or by L-NAME. These results suggested that ketamine-induced relaxation of the rabbit renal artery is endothelium-independent and rules out an involvement of NO in the relaxation responses to ketamine, suggesting that ketamine may directly act on vascular smooth muscle.

The cellular mechanism underlying ketamine-mediated relaxation of vascular smooth muscle is not fully understood, although opening of some K^+^ channels and inhibition of Ca^2+^ availability have been suggested as being involved in the relaxation of intravenous anesthetics \[[@B5],[@B6],[@B11]\]. High K^+^ leads to cell membrane depolarization, and consequently voltage-gated Ca^2+^ channels open, transmembrane Ca^2+^ influx increases, and finally vascular smooth muscle contract. On the other hand, most receptor agonists contract vascular smooth muscles by both eliciting transmembrane Ca^2+^ influx through corresponding receptor-operated Ca^2+^ channels and mobilizing intracellular Ca^2+^ from intracellular Ca^2+^ stores \[[@B9]\]. The present study shows that ketamine decrease both KCl- and histamine-evoked contractions. The relaxant effect of ketamine on KCl- and histamine-evoked contractions may be due to the following two mechanisms 1) indirect inhibition of Ca^2+^ influx following the activation of K^+^ channels and 2) direct inhibition of Ca^2+^ influx. A probable site of action is K^+^ channels; an increase in K^+^ current hyperpolarizes the membrane. K^+^ channels play an essential role in regulating vascular tone \[[@B10],[@B16]\]. Ketamine mediates the activation of both BK~Ca~ channels in the porcine coronary artery \[[@B4]\], and ATP-sensitive K^+^ (K~ATP~) channels in the rat mesenteric artery and canine pulmonary artery \[[@B3],[@B17]\]. On the other hand, some reported that ketamine blocks voltage gated K^+^ (K~v~) channels) in rat mesenteric arteries and K~ATP~ in rat myocardium \[[@B18],[@B19]\]. These data suggest that the subtypes of K^+^ channels involved in ketamine-mediated relaxation of arteries appear to be both tissue- and species-dependent. However, subtypes of K^+^ channels involved in ketamine-mediated relaxation are not fully understood. In the present study, ketamine-induced relaxation was significantly reduced either by TEA, non-specific K^+^ channel blocker, or by iberiotoxin, an inhibitor of BK~Ca~ channels. On the other hand, ketamine-induced relaxation was not affected either by 4-AP, a specific inhibitor of K~v~ channels, or by glibenclamide, a specific inhibitor of K~ATP~ channels, suggesting that K~v~ or K~ATP~ channels are not involved in ketamine-mediated relaxation of the rabbit renal artery. Since TEA and iberiotoxin inhibits BK~Ca~ channels, this leads to the conclusion that BK~Ca~ channels are likely to play a role in ketamine-induced relaxation. Taken together, these data clearly indicate that in the rabbit renal artery, the BK~Ca~ channels are involved in ketamine-mediated, NO-independent relaxation.

In smooth muscles, the agonist-induced elevation of \[Ca^2+^\]~cyt~ was due to the following: 1) activation of Ca^2+^ influx, 2) activation of Ca^2+^ release from sarcoplasmic reticulum (SR), and 3) inhibition of Ca^2+^ sequestration into intracellular stores \[[@B9]\]. The vasorelaxation of ketamine is believed to be mediated by inhibiting both Ca^2+^ influx, through L-type Ca^2+^ channels, and Ca^2+^ release from the internal Ca^2+^ stores \[[@B9],[@B20]\]. However, in some vascular smooth muscles, ketamine had no significant on calcium intake into intracellular stores or on calcium extrusion \[[@B21],[@B22]\]. Since there were no differences in the degree of ketamine-induced relaxation in the absence and presence of either ryanodine or thapsigargin, it suggests the possibility that ketamine caused vasodilation in isolated rabbit renal arteries without involvement of Ca^2+^ release from internal stores. Further investigation of ketamine actions at subcellular levels will enhance our understanding of the relaxant properties.

Another aspect investigated in the present study was whether ketamine-induced vasorelaxation was related to inhibition of Ca^2+^ influx from the extracellular medium. Ketamine relaxed preparations precontracted with KCl or histamine in a concentration-dependent manner. It also inhibited Ca^2+^-induced contractions in Ca^2+^-free mediums containing high K^+^. In vascular smooth muscles, ketamine inhibits L-type Ca^2+^ channels, and reduces Ca^2+^ influx \[[@B20]-[@B24]\]. Taken together, these results support that ketamine can block Ca^2+^ influx through Ca^2+^ channels presented in the vascular smooth muscles.

In summary, the results indicated that in the rabbit renal artery, ketamine inhibited both KCl-and histamine-evoked contractions. Ketamine may evoke activation of BK~Ca~ channels and thereby inhibit voltage-gated Ca^2+^ influx in a prolonged manner.

![Average concentration-response curves for the relaxant effects of ketamine on contraction induced by 50 mM KCl (●) and 10 µM histamine (○). Ketamine (0.1-100 µl/ml) was cumulatively added after the contraction reached a steady state. Responses are expressed as the percentage of contraction elicited by either 50 mM KCl or 10 µM histamine before addition of ketamine. Each point represents the mean of 8 rings and SEM is shown by vertical bar.](kjae-63-533-g001){#F1}

![(A) Typical recordings showing the effects of L-N^G^-Nitroarginine Methyl Ester (L-NAME), nitric oxide synthase blocker, on ketamine (30 µg/ml)-induced relaxation in a rabbit renal artery precontracted with 10 µM histamine. Original tracing show the ketamine-induced relaxation in the absence and presence of L-NAME (0.1 mM). (B) Summarized data showing the effect of L-NAME or endothelium removal on histamine-evoked contraction. Columns which are the mean ± SEM from 6 separate experiments, represent the effects of under control conditions (Control) and in the presence of L-NAME or the condition of endothelium removal.](kjae-63-533-g002){#F2}

![Summarized data showing the inhibitory effects of K^+^ channel blockers on ketamine (30 µg/ml)-induced relaxation. Columns which are the mean ± SEM from 6 separate experiments, represent the effects of under control conditions (Control) and in the presence of glibenclamide (10 µM), 4-aminopyridine (5 mM), tetraethylammonium (10 mM) or iberiotoxin (0.1 µM). ^\*^P \< 0.05, versus control (paired t-test).](kjae-63-533-g003){#F3}

![Summarized data showing the inhibitory effects of thapsigargin (10 µM) and ryanodine (10 µM) on ketamine (30 µg/ml)-induced relaxation. Columns which are the mean ± SE mean from 5 separate experiments, represent the effects of under control conditions (Control) and in the presence of thapsigargin (10 µM) or ryanodine (10 µM).](kjae-63-533-g004){#F4}

![Traces showing ketamine (30 µg/ml)-induced relaxation in rabbit renal arteries contracted by 50 mM KCl in the absence (●) and presence (○) of ketamine (A). 100% represents the 50 mM KCl-induced sustained increase in force before washout. Each point represents the mean of 5 rings and SEM is shown by vertical bar. ^\*^P \< 0.05, versus control (paired t-test). ^†^P \< 0.05, versus control (ANOVA followed by Scheffe\'s F test for post hoc analysis).](kjae-63-533-g005){#F5}
